GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study May 31, 2019
GRAIL Announces Promising New Data with Early Detection Blood Test to be Presented at ASCO May 15, 2019
GRAIL Announces Significant Progress with Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation May 13, 2019
GRAIL Announces Plans to Initiate SUMMIT Study to Support Development of Blood Test for Early Cancer Detection December 3, 2018
GRAIL to Present New Data from the Circulating Cell-free Genome Atlas (CCGA) Study at the European Society for Medical Oncology (ESMO) 2018 Congress October 19, 2018